Description
Peptide Blend
CGL is a research blend combining Cagrilintide with a GLP-1 receptor agonist compound, studied for combined amylin- and incretin-pathway signaling in metabolic research.
Specifications
| Format | Lyophilized powder, 5mg per vial |
| Purity | ≥98% per component (HPLC verified) |
| Storage | -20°C lyophilized, protected from light and moisture; 2-8°C after reconstitution |
✓ Certificate of Analysis available for this production lot — view our testing process
In the Lab
CGL pairs the amylin and incretin pathways in a single blend, similar in spirit to Cagrilintide/Semaglutide, giving researchers another combined-signaling option for metabolic study designs.
Reviews
There are no reviews yet.